Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 23 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

61%

14 trials in Phase 3/4

Results Transparency

0%

0 of 10 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3
13(61.9%)
Phase 1
7(33.3%)
Phase 4
1(4.8%)
21Total
Phase 3(13)
Phase 1(7)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (23)

Showing 20 of 23 trials
NCT06717360Phase 3Completed

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R

Role: lead

NCT05503953Phase 3Completed

Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Inadequately Controlled With AGLS

Role: lead

NCT07198347Phase 3Not Yet Recruiting

Efficacy and Safety of AG2001 in Patients With Acute Bronchitis

Role: lead

NCT07083206Recruiting

A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe

Role: lead

NCT06916169Phase 1Not Yet Recruiting

A Study to Evaluate the Safety and Pharmacokinetics of AG2304 Compared to Coadministration of AG23041 and AG23042

Role: lead

NCT06549504Phase 1Not Yet Recruiting

Bioequivalence Study of AG2202

Role: lead

NCT05344638Phase 3Completed

A Clinical Trial to Evaluate the Safety and Efficacy of "AG1904" in Acute Bronchitis

Role: lead

NCT05206578Phase 3Unknown

Study to Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia

Role: lead

NCT04686643Phase 3Unknown

Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension

Role: lead

NCT04554303Unknown

Comparing Safety and Efficacy of Amlodipine Verses S Amlodipine in Patients With Essential Hypertension

Role: lead

NCT03623282Phase 4Completed

Study Regarding the Clinical Efficacy of Synatura® in Patients With Chronic Bronchitis Type COPD

Role: lead

NCT01982916Phase 3Completed

Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean

Role: lead

NCT02614352Phase 1Unknown

Investigate a Pharmacokinetic Characteristics and the Safety of AG1502 in Healthy Male Subjects

Role: lead

NCT01536353Phase 1Completed

Clinical Trial to Evaluate the Bioavailability and Safety of AGSAV301

Role: lead

NCT02609711Phase 1Unknown

Investigate a Interaction of Candesartan and Atorvastatin in Healthy Male Sugjects

Role: lead

NCT02274961Phase 3Unknown

S-pantoprazole 10mg Phase III Clinical Study

Role: lead

NCT01882296Phase 1Unknown

Investigate a Pharmacodynamics Between S-pantoprazole 10, 20, 40mg and Pantoprazole 20, 40mg in Healthy Male Subjects

Role: lead

NCT01821521Phase 1Unknown

Investigate a Pharmacokinetics Between S-pantoprazole 20mg and Pantoprazole 40mg in Healthy Male Subjects

Role: lead

NCT01400945Phase 3Completed

Efficacy Study of AGSPT201 Tablet to Treat Gastroesophageal Reflux Disease

Role: lead

NCT01416480Phase 3Completed

Clinical Trial to Evaluate the Safety and Efficacy of "Theobromine Capsule" as an Antitussive in Acute Cougher

Role: lead